Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1991 Jun;66(6):706–709. doi: 10.1136/adc.66.6.706

Occurrence, clinical manifestations, and prognosis of Guillain-Barré syndrome.

H Rantala 1, M Uhari 1, M Niemelä 1
PMCID: PMC1793142  PMID: 2053793

Abstract

In order to obtain more information on the incidence of Guillain-Barré syndrome and recent developments in its prognosis, we analysed the severity and prognosis of Guillain-Barré syndrome in children diagnosed and treated during the years 1980-6 throughout Finland. The criteria for Guillain-Barré syndrome were fulfilled in 14 boys and 13 girls. The mean annual number of cases of Guillain-Barré syndrome was thus 3.9, giving a mean annual incidence of 0.38/100,000 of population under 15 years of age (95% confidence intervals 0.25 to 0.56/100,000). The incidence of Guillain-Barré syndrome causing permanent neurological defects in children under 15 years of age was 1.4/10 million annually (95% confidence intervals 0.035 to 7.8/10 million). Our figures appeared to be one fourth to a half of that reported earlier in children and even lower than those in adults. Although there were no deaths among our patients, mortality from Guillain-Barré syndrome seems to have remained similar for the last 20 years despite current awareness of the possibility of cardiac arrest and respiratory failure.

Full text

PDF
707

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Briscoe D. M., McMenamin J. B., O'Donohoe N. V. Prognosis in Guillain-Barré syndrome. Arch Dis Child. 1987 Jul;62(7):733–735. doi: 10.1136/adc.62.7.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cole G. F., Matthew D. J. Prognosis in severe Guillain-Barré syndrome. Arch Dis Child. 1987 Mar;62(3):288–291. doi: 10.1136/adc.62.3.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Evans O. B. Polyneuropathy in childhood. Pediatrics. 1979 Jul;64(1):96–105. [PubMed] [Google Scholar]
  4. Greenwood R. J., Newsom-Davis J., Hughes R. A., Aslan S., Bowden A. N., Chadwick D. W., Gordon N. S., McLellan D. L., Millac P., Stott R. B. Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet. 1984 Apr 21;1(8382):877–879. doi: 10.1016/s0140-6736(84)91341-2. [DOI] [PubMed] [Google Scholar]
  5. Hankey G. J. Guillain-Barré syndrome in Western Australia, 1980-1985. Med J Aust. 1987 Feb 2;146(3):130–133. doi: 10.5694/j.1326-5377.1987.tb120153.x. [DOI] [PubMed] [Google Scholar]
  6. Hogg J. E., Kobrin D. E., Schoenberg B. S. The Guillain-Barré syndrome epidemiologic and clinical features. J Chronic Dis. 1979;32(3):227–231. doi: 10.1016/0021-9681(79)90068-7. [DOI] [PubMed] [Google Scholar]
  7. Hughes R. A., Newsom-Davis J. M., Perkin G. D., Pierce J. M. Controlled trial prednisolone in acute polyneuropathy. Lancet. 1978 Oct 7;2(8093):750–753. doi: 10.1016/s0140-6736(78)92644-2. [DOI] [PubMed] [Google Scholar]
  8. Kennedy R. H., Danielson M. A., Mulder D. W., Kurland L. T. Guillain-Barré syndrome: a 42-year epidemiologic and clinical study. Mayo Clin Proc. 1978 Feb;53(2):93–99. [PubMed] [Google Scholar]
  9. Khatri B. O., Flamini J. R., Baruah J. K., Dobyns W. B., Konkol R. J. Plasmapheresis with acute inflammatory polyneuropathy. Pediatr Neurol. 1990 Jan-Feb;6(1):17–19. doi: 10.1016/0887-8994(90)90073-a. [DOI] [PubMed] [Google Scholar]
  10. Kleyweg R. P., van der Meché F. G., Loonen M. C., de Jonge J., Knip B. The natural history of the Guillain-Barré syndrome in 18 children and 50 adults. J Neurol Neurosurg Psychiatry. 1989 Jul;52(7):853–856. doi: 10.1136/jnnp.52.7.853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. LOW N. L., SCHNEIDER J., CARTER S. Polyneuritis in children. Pediatrics. 1958 Nov;22(5):972–990. [PubMed] [Google Scholar]
  12. Markland L. D., Riley H. D., Jr The Guillain-Barré syndrome in childhood. A comprehensive review, including observations on 19 additional cases. Clin Pediatr (Phila) 1967 Mar;6(3):162–170. doi: 10.1177/000992286700600314. [DOI] [PubMed] [Google Scholar]
  13. Osterman P. O., Fagius J., Lundemo G., Pihlstedt P., Pirskanen R., Sidén A., Säfwenberg J. Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet. 1984 Dec 8;2(8415):1296–1299. doi: 10.1016/s0140-6736(84)90819-5. [DOI] [PubMed] [Google Scholar]
  14. Paulson G. W. The Landry-Guillain-Barré-Strohl syndrome in childhood. Dev Med Child Neurol. 1970 Oct;12(5):604–607. doi: 10.1111/j.1469-8749.1970.tb01969.x. [DOI] [PubMed] [Google Scholar]
  15. Rossi L. N., Mumenthaler M., Lütschg J., Ludin H. P. Guillain-Barré syndrome in children with special reference to the natural history of 38 personal cases. Neuropadiatrie. 1976 Feb;7(1):45–51. [PubMed] [Google Scholar]
  16. Shahar E., Murphy E. G., Roifman C. M. Benefit of intravenously administered immune serum globulin in patients with Guillain-Barré syndrome. J Pediatr. 1990 Jan;116(1):141–144. doi: 10.1016/s0022-3476(05)81667-1. [DOI] [PubMed] [Google Scholar]
  17. Uhari M., Rantala H., Niemelä M. Cluster of childhood Guillain-Barré cases after an oral poliovaccine campaign. Lancet. 1989 Aug 19;2(8660):440–441. doi: 10.1016/s0140-6736(89)90609-0. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES